M&A Corner
Cosmos Health Set for Substantial Growth From Acquisitions Completed in 202302 Jan 2024
Cosmos Health Inc. forecasts significant revenue growth and financial milestones driven by its 2023 acquisitions of Cana Laboratories, Bikas GP’s... Continue Reading
|
Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio02 Jan 2024
Bristol Myers Squibb (NYSE: BMY) and RayzeBio, Inc. (NASDAQ: RYZB) today announced a definitive merger agreement under which Bristol Myers... Continue Reading
|
Senhwa Biosciences Received Taiwan FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection02 Jan 2024
Senhwa Biosciences secures Taiwan FDA approval for Phase II trials of Silmitasertib (CX-4945) to treat community-acquired pneumonia (CAP) from viral... Continue Reading
|
Immunome to Acquire Antibody-Related Assets and Materials from Atreca02 Jan 2024
Heranova Lifesciences, a Boston-based women’s health startup, launches with $13.5 million in seed funding, focusing on reproductive health solutions, including... Continue Reading
|
Women’s Health Company Heranova Lifesciences Launches with $13.5M.02 Jan 2024
Heranova Lifesciences, a Boston-based women’s healthcare startup, launches with $13.5 million in seed funding, focusing on reproductive health solutions. Offering... Continue Reading
|
Women-Led Pakistani Telehealth Startup Bags $3M Series A Funding02 Jan 2024
Sehat Kahani, a Pakistani telemedicine startup, secures $2.7 million in Series A funding led by Amaanah Circle. Founded by two... Continue Reading
|
Christiana Care Pays $47 Million to Settle Alleged kickback Scheme.02 Jan 2024
ChristianaCare Health System settles a whistleblower lawsuit, paying over $47 million without admitting liability for alleged kickbacks to physicians for... Continue Reading
|
Carrum Health, Florida Cancer Institute Partner to Expand Breast Cancer Care.02 Jan 2024
Carrum Health, a digital marketplace for employer healthcare, collaborates with Florida Cancer Specialists & Research Institute to offer breast cancer... Continue Reading
|
Intelligent Scopes and Mayo Clinic Partner to Develop AI-Powered Tools for Bladder Cancer02 Jan 2024
Claritas HealthTech Ltd.’s subsidiary, Intelligent Scopes Corp, and Mayo Clinic have united to pioneer AI solutions for bladder cancer care.... Continue Reading
|
AstraZeneca to Acquire Gracell, Furthering Cell Therapy Ambition Across Oncology and Autoimmune Diseases02 Jan 2024
AstraZeneca’s definitive agreement to acquire Gracell Biotechnologies Inc. aims to bolster its cell therapy endeavors, adding GC012F, a novel CAR-T... Continue Reading
|